The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as...
Vous n'êtes pas connecté
THURSDAY, Sept. 12, 2024 -- Ozempic and Wegovy can prevent heart problems in overweight and obese people, particularly if they also suffer from kidney disease, a new clinical trial shows. The drugs’ active ingredient, semaglutide, reduced...
The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as...
The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as...
FRIDAY, Sept. 13, 2024 -- Ozempic and its weight-loss cousin, Wegovy, outperform another longstanding weight-loss drug that targets the same hormone...
TUESDAY, Sept. 17, 2024 -- A small clinical trial suggests that a duo of drugs can extend survival for people battling advanced kidney...
Pharmaceuticals such as Ozempic, Wegovy and Mounjaro aren't risk-free. The FDA says it has received reports of people overdosing on compounded...
Pharmaceuticals such as Ozempic, Wegovy and Mounjaro aren't risk-free. The FDA says it has received reports of people overdosing on compounded...
MONDAY, Sept. 9, 2024 -- A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the...
TUESDAY, Sept. 3, 2024 -- The booming popularity of the weight-loss drug semaglutide has prompted increasing concerns about potential side effects...
Researchers are finding heat-related illnesses can also contribute to heart disease and cognitive impairment
Recent studies suggest a potential link between semaglutide-based medications, such as Ozempic, and an increased risk of suicidal thoughts.